Edward A. Stadtmauer, MD, on CRISPR-Edited T Cells for Multiple Myeloma

Posted: Friday, January 17, 2020

Edward A. Stadtmauer, MD, of the University of Pennsylvania Abramson Cancer Center, describes his early findings and explains how this work might eventually lead to novel approaches for patients with heavily pretreated multiple myeloma and sarcoma.